triiodothyronine (T3), thyroxine (T4), and free T4 concentrations, whereas \g=b\-subunit TSH was undetectable. Exogenous TRH failed to increase serum TSH. Serum TSH was markedly suppressed by glucocorticoid, but was increased by antithyroid drug. l-Dopa or bromocriptine partially suppressed, but nomifensine had no influence on serum TSH. Serum prolactin (Prl) , normal value less than 30 pg/I; serum GH (Dainabot Co., Japan), normal value less than 5 µ /l; serum T4 and T3 (Yamazaki et al. 1981) , normal values 71-142 and 1.2-3.1 nmol/1, respectively; serum thyroxine-binding globulin (TBG) (Table 2 ). As shown in Table 3 , the in¬ creased serum Prl had decreased 6 h after admini¬ stration of 2.5 mg of bromocriptine or 500 mg of L-Dopa. However, nomifensine had no effect. Basal growth hormone (GH) levels were constantly low and showed poor response to administration of insulin, l.-Dopa and nomifensine (Table 3) (Table 3) .
As shown in Fig. 2 (Emerson & Utiger 1972) in a patient with hvperthyroidism and excessive TSH secretion, but without evidence of a pituitary tumour, and was considered to be due to excessive TRH-secretion.
In normal subjects, the TSH responses are not greater after iv administration of 800 µg than after 400 µg of TRH (Snyder & Utiger 1972 (Barbarino et al. 1980; Horn et al. 1976; Lamberg et al. 1983; Meinders et al. 1981) . It has been demonstrated (Feek et al. 1980) (Feek et al. 1980 
